跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Canisar - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Canisar
Approved
STANDARD
Canisar
Sichuan Huiyu Pharmaceutical Company Limited.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
e32ff2408cd2b0ba
Company
Sichuan Huiyu Pharmaceutical Company Limited.
Type
Standard
Approval Details
Approval Id
e32ff2408cd2b0ba
Drug Approval Philippines Name
Canisar
Product Name
Canisar
Registration Number
DR-XY49117
Brand Name
Canisar
Generic Name
Irinotecan Hydrochloride
Dosage Form
Concentrate Solution for IV Infusion
Dosage Strength
20 mg/mL
Manufacturer
Sichuan Huiyu Pharmaceutical Company Limited.
Importer
Oncolife Corporation
Distributor
Oncolife Corporation
Issuance Date
25 March 2025
Expiry Date
28 June 2029
Pharmacologic Category
Antineoplastic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
e32ff2408cd2b0ba
Type
Standard
Back to Philippines FDA Approvals